Our findings underscore the value of phosphoproteomics in capturing molecular phenomena such as ERK pathway activation, a key pathological biomarker in synucleinopathy progression that has been challenging to detect using other omics approaches, while highlighting the relevance of the aSyn PFF model in recapitulating early pathological changes. The gene discussed is MAPK1; the disease is synucleinopathy.